The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats
Biomolecules · 2023
DOI: 10.3390/biom13020364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Nazarine Mokhtar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Université Clermont Auvergne, INSERM, NEURO-DOL, 63000 Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Diabetes Mellitus, Experimental, Neuralgia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche (ANR), Investissements d'Avenir, Investissements d’Avenir.
Abstract (Originalsprache)
Diabetic neuropathy is often associated with chronic pain. Serotonin type 6 (5-HT6) receptor ligands, particularly inverse agonists, have strong analgesic potential and may be new candidates for treating diabetic neuropathic pain and associated co-morbid cognitive deficits. The current study addressed the involvement of 5-HT6 receptor constitutive activity and mTOR signaling in an experimental model of diabetic neuropathic pain induced by streptozocin (STZ) injection in the rat. Here, we show that mechanical hyperalgesia and associated cognitive deficits are suppressed by the administration of 5-HT6 receptor inverse agonists or rapamycin. The 5-HT6 receptor ligands also reduced tactile allodynia in traumatic and toxic neuropathic pain induced by spinal nerve ligation and oxaliplatin injection. Furthermore, both painful and co-morbid cognitive symptoms in diabetic rats are reduced by intrathecal delivery of a cell-penetrating peptide that disrupts 5-HT6 receptor-mTOR physical interaction. These findings demonstrate the deleterious influence of the constitutive activity of spinal 5-HT6 receptors upon painful and cognitive symptoms in diabetic neuropathic pains of different etiologies. They suggest that targeting the constitutive activity of 5-HT6 receptors with inverse agonists or disrupting the 5-HT6 receptor-mTOR interaction might be valuable strategies for the alleviation of diabetic neuropathic pain and cognitive co-morbidities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Université Clermont Auvergne, INSERM, NEURO-DOL, 63000 Clermont-Ferrand, France.
- IBMM, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
- Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna Str., 30-688 Kraków, Poland.
- Institut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
ORCID-Profile: Youssef Aissouni, Vittorio Canale, Frédéric Lamaty, Paweł Zajdel, Philippe Marin, Christine Courteix
Förderung
- Agence Nationale de la Recherche (ANR)
- Investissements d'Avenir
- Investissements d’Avenir
- Institut National de la Santé et de la Recherche Médicale (INSERM)
- Centre National de la Recherche Scientifique (CNRS)
- Auvergne-Rhône-Alpes Région (France)
- Université Clermont Auvergne
- Université de Montpellier
Zitieren
APA
Mokhtar, N., Drop, M., Jacquot, F., Lamoine, S., Chapuy, E., Prival, L., Aissouni, Y., Canale, V., Lamaty, F., Zajdel, P., Marin, P., Doly, S., & Courteix, C. (2023). The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats. Biomolecules. https://doi.org/10.3390/biom13020364
Vancouver
Mokhtar N, Drop M, Jacquot F, Lamoine S, Chapuy E, Prival L, et al. The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats. Biomolecules. 2023. doi:10.3390/biom13020364
BibTeX
@article{Mokhtar2023,
author = {Mokhtar, Nazarine and Drop, Marcin and Jacquot, Florian and Lamoine, Sylvain and Chapuy, Eric and Prival, Laetitia and Aissouni, Youssef and Canale, Vittorio and Lamaty, Frédéric and Zajdel, Paweł and Marin, Philippe and Doly, Stéphane and Courteix, Christine},
title = {The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats},
journal = {Biomolecules},
year = {2023},
doi = {10.3390/biom13020364}
}
EUVIMED